GT201400067A - Moduladores selectivos del receptor androgeno - Google Patents

Moduladores selectivos del receptor androgeno

Info

Publication number
GT201400067A
GT201400067A GT201400067A GT201400067A GT201400067A GT 201400067 A GT201400067 A GT 201400067A GT 201400067 A GT201400067 A GT 201400067A GT 201400067 A GT201400067 A GT 201400067A GT 201400067 A GT201400067 A GT 201400067A
Authority
GT
Guatemala
Prior art keywords
selective modulators
androgen receiver
androgen
receiver selective
modulators
Prior art date
Application number
GT201400067A
Other languages
English (en)
Inventor
Prabhakar Kondaji Jadhav
Ashraf Saeed
Jonathan Edward Green
Venkatesh Krishnan
Donald Paul Matthews
Gregory Alan Stephenson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47046879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201400067(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201400067A publication Critical patent/GT201400067A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA PRESENTE INVENCIÓN PROPORCIONA MODULADORES DEL RECEPTOR DE ANDRÓGENOS SELECTIVO NOVEDOSOS Y SUS SALES Y COMPOSICIONES FARMACÉUTICAS DE LOS MISMOS.
GT201400067A 2011-10-13 2014-04-11 Moduladores selectivos del receptor androgeno GT201400067A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161546711P 2011-10-13 2011-10-13

Publications (1)

Publication Number Publication Date
GT201400067A true GT201400067A (es) 2015-02-27

Family

ID=47046879

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201400067A GT201400067A (es) 2011-10-13 2014-04-11 Moduladores selectivos del receptor androgeno

Country Status (27)

Country Link
US (1) US8658693B2 (es)
EP (1) EP2766350B1 (es)
JP (1) JP6002228B2 (es)
KR (1) KR20140067102A (es)
CN (1) CN103842348B (es)
AP (1) AP2014007548A0 (es)
AR (1) AR088082A1 (es)
AU (1) AU2012321113B2 (es)
BR (1) BR112014008668A2 (es)
CA (1) CA2847889A1 (es)
CL (1) CL2014000895A1 (es)
CO (1) CO6910195A2 (es)
CR (1) CR20140156A (es)
DO (1) DOP2014000075A (es)
EA (1) EA201490519A1 (es)
EC (1) ECSP14013305A (es)
ES (1) ES2626820T3 (es)
GT (1) GT201400067A (es)
IL (1) IL231440A0 (es)
MX (1) MX2014004558A (es)
PE (1) PE20141669A1 (es)
PL (1) PL2766350T3 (es)
PT (1) PT2766350T (es)
SG (1) SG11201401794YA (es)
TN (1) TN2014000136A1 (es)
TW (1) TWI449686B (es)
WO (1) WO2013055577A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140045856A1 (en) 2012-07-31 2014-02-13 Boehringer Ingelheim International Gmbh 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
TW201534586A (zh) * 2013-06-11 2015-09-16 Orion Corp 新穎ｃｙｐ１７抑制劑／抗雄激素劑
WO2015082324A1 (en) 2013-12-04 2015-06-11 Boehringer Ingelheim International Gmbh Sulfoximine substituted quinazolines for pharmaceutical compositions
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
WO2015169677A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Sulfoximine substituted quinazolines for pharmaceutical compositions
KR102236605B1 (ko) 2016-08-15 2021-04-05 화이자 인코포레이티드 피리도피리미딘온 cdk2/4/6 억제제
LT3507289T (lt) 2016-09-02 2020-10-12 Suven Life Sciences Limited Muskarininio m1 receptoriaus atžvilgiu teigiami alosteriniai moduliatoriai
US11076596B2 (en) 2017-09-18 2021-08-03 Basf Se Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594405A (en) * 1968-05-17 1971-07-20 Du Pont Substituted pyranyl anilines as plant growth modifiers
DE60208630T2 (de) * 2001-05-11 2006-08-17 Pfizer Products Inc., Groton Thiazolderivate und ihre Verwendung als cdk-Inhibitoren
WO2005090282A1 (en) * 2004-03-12 2005-09-29 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
JP5089578B2 (ja) * 2005-05-13 2012-12-05 イーライ リリー アンド カンパニー 選択的なアンドロゲン受容体調節物質としての置換型ｎ−アリールピロリジン
RU2008126228A (ru) * 2005-11-30 2010-01-10 Астеллас Фарма Инк. (Jp) 2-аминобензамидное производное
EP2146967A2 (en) * 2007-04-16 2010-01-27 Serenex, Inc. Tetrahydroindole and tetrahydroindazole derivatives
US8190467B2 (en) * 2007-10-19 2012-05-29 Michelle Letendre-Hedlund Methods of identifying environmentally friendly businesses or individuals
AU2009215843B2 (en) * 2008-02-22 2011-09-08 Ellipses Pharma Ltd Selective androgen receptor modulators

Also Published As

Publication number Publication date
IL231440A0 (en) 2014-04-30
CN103842348B (zh) 2015-08-19
TW201329026A (zh) 2013-07-16
PL2766350T3 (pl) 2017-08-31
US8658693B2 (en) 2014-02-25
CO6910195A2 (es) 2014-03-31
EP2766350A1 (en) 2014-08-20
ES2626820T3 (es) 2017-07-26
CN103842348A (zh) 2014-06-04
JP6002228B2 (ja) 2016-10-05
JP2014530818A (ja) 2014-11-20
PT2766350T (pt) 2017-05-22
US20130217762A1 (en) 2013-08-22
CA2847889A1 (en) 2013-04-18
AR088082A1 (es) 2014-05-07
DOP2014000075A (es) 2014-06-01
EP2766350B1 (en) 2017-04-05
MX2014004558A (es) 2014-08-01
KR20140067102A (ko) 2014-06-03
AP2014007548A0 (en) 2014-03-31
AU2012321113A1 (en) 2014-03-27
BR112014008668A2 (pt) 2017-04-25
EA201490519A1 (ru) 2014-09-30
ECSP14013305A (es) 2014-05-31
AU2012321113B2 (en) 2015-07-09
WO2013055577A1 (en) 2013-04-18
PE20141669A1 (es) 2014-11-08
TWI449686B (zh) 2014-08-21
CL2014000895A1 (es) 2014-08-22
CR20140156A (es) 2014-05-16
SG11201401794YA (en) 2014-09-26
TN2014000136A1 (en) 2015-07-01

Similar Documents

Publication Publication Date Title
GT201400067A (es) Moduladores selectivos del receptor androgeno
CO2017002532A2 (es) Indazoles sustituidos con bencilo como inhibidores de bub1
CR20140479A (es) Moduladores del receptor del estrogeno y sus usos
MA43382A (fr) Modulateurs des récepteurs des chimiokines
ECSP17023281A (es) Inhibidores de mk2 y sus usos
CR20150462A (es) Inhibidores de erk y sus usos
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
CR20150049A (es) Anticuerpos e inmunoconjugados anti-cd79b
CO7350623A2 (es) Agentes moduladores de autotaxina (atx)
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
UY34876A (es) Anticuerpos anti-egfr y usos de los mismos
UY33504A (es) N-etil-n-fenil-1,2-dihidro-4-hidroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida deuterada, sales y usos de la misma
SMT201700009B (it) Modulatori del recettore x del fegato
UA109931C2 (xx) Піримідинциклогексильні модулятори глюкокортикоїдних рецепторів
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
CR20160184A (es) Piperidil-etil-pirimidina sustituido como inhibidor de ghrelin o-acil transferasa
UY34538A (es) Heteroarilos y usos de los mismos
BR112014026926A2 (pt) uso terapêutico de produtos de semente de chardonnay
TR201909271T4 (tr) Testosteron formülasyonları.
CO7020877A2 (es) Anticuerpos anti-asic1 y usos de los mismos
IN2014KN02993A (es)
DK3145916T3 (da) Imidazolderivater som formylpeptidreceptormodulatorer
BR112015005738A2 (pt) formulações orais de angiotensina
UY34595A (es) Composición farmacéutica de liberación prolongada de trimetazidina
CO6852071A2 (es) Moduladores alostéricos positivos del receptor de acetilcolina nicotínico